Improving practice . . . Advancing patient care  

American Urological Association (AUA) Primary Care Update in Urology Webcast


American Urological Association (AUA) Primary Care Update in Urology Webcast

Topic: Urology
Relevant Terms: Benign Prostatic Hyperplasia (BPH), Cardiometabolic Syndrome, ED/Hypogonadism, Geriatrics, Hypertension, Lower Urinary Tract Symptoms (LUTS), Overactive Bladder (OAB), Pediatric Urology, Prostate Cancer And Kidney
Primary Audience: Primary care providers (MDs/ DOs/ NPs/ PAs)
Launch Date: 03-Jul-12
Credits: AMA PRA Category 1 Credits
3 AAFP CME Credits
Expiration Date: The accreditation for this activity has expired.

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Discuss screening methods, causes and treatment options of erectile dysfunction, hypogonadism and metabolic syndrome
  2. Outline specific urologic conditions in the elderly population
  3. Describe screening methods, identification and treatment options of Lower Urinary Tract Symptoms (LUTS), Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
  4. Discuss the surgically correctable causes of hypertension
  5. Outline basic pediatric urologic problems and their management including urinary tract infections, enuresis, undescended testis and torsion of the testis
  6. Explain screening, detection, treatment and impact of prostate cancer
  7. Review risk factors, identification, and how to manage kidney stone disease


    Eric R. Sargent, MD
    Associate Professor
    Department of Surgery
    Division of Urology
    University of Vermont
    Burlington, VT
    Howard N. Winfield, MD
    Director, Urology and Robotic Surgery
    DCH Regional Health System
    West Alabama Urology Associates
    Tuscaloosa, AL
    Ajay Nehra, MD
    Mayo Clinic
    Rochester, MN
    Brian R. Matlaga, MD
    Associate Professor of Urology
    Johns Hopkins University School of Medicine
    Director of Ambulatory Care, James Buchanan Brady Urological Institute
    Director of Stone Disease, Brady Urological Institute
    Baltimore, MD
    Matthew Thom, MD
    West Alabama Urology Associates
    Tuscaloosa, AL
    Matthew T. Rosenberg, MD
    Medical Director
    Mid Michigan Health Centers
    Jackson, MI
    Tomas Griebling, MD
    John P. Wolf 33° Masonic Distinguished Professor of Urology
    University of Kansas
    Professor, Vice Chair, Residency Program Director
    Assistant Dean for Student Affairs
    School of Medicine
    University of Kansas
    Kansas City, KS

    Method of Participation
    1. Read the CME information.
    2. Click "Enter the Activity" link located at the bottom of the page.
    3. Login with your Epocrates or CME Companion user ID and password. If you do not have an Epocrates or CME Companion account, you will be prompted to create one. It is recommended that you use your email address for your username and a password when creating your account.
    4. To claim credit, complete the pre-test, view the webcast, pass the posttest with 80% accuracy and submit the evaluation.

    CME Information

    Program Description
    The purpose of this program is to aid primary care providers in screening, detection and referral of common urological health issues. Topics to be addressed include ED/Hypogonadism and Cardiometabolic Syndrome, Geriatrics in Urology, Lower Urinary Tract Symptoms (LUTS)/Overactive Bladder (OAB)/Benign Prostatic Hyperplasia (BPH), Hypertension: Surgically Correctable Etiologies, Pediatric Urology, Prostate Cancer and Kidney Stone Disease.

    The American Urological Association Education & Research, Inc. (AUAER) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Credit Designation
    American Urological Association
    The American Urological Association Education & Research, Inc. designates this enduring material for a maximum of 3.00 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    American Academy of Family Physicians This Enduring Material activity, Primary Care Update in Urology, has been reviewed and is acceptable for up to 3 Prescribed credit(s) by the American Academy of Family Physicians.
    AAFP certification begins June 29, 2012. Term of approval is for one year from this date with the option of yearly renewal. Physicians should claim only the credit commensurate with the extent
    of their participation in the activity.

    The AUAER takes responsibility for the content, quality, and scientific integrity of this CME activity.

    Medium or Combination of Media Used

    Method of Participation in the Learning Process
    Participants must complete the pre-test, view the webcast, pass the posttest with 80% accuracy and submit the evaluation to claim credit and print a certificate for this activity.

    Navigation Instructions
    A segmented, navigational bar is located at the top of the screen for participants to monitor their progress during the activity.  Each segment represents a page of the activity. As you complete each page of the activity, a pointer moves to the right.  The activity begins with a pre-test and review (pages 1-2). This is followed by the activity content/presentations (pages 3-10), activity feedback and references (page 11), posttest (pages 12-13), pre-posttest results (page 14), evaluation form (page 15) and claim credit form (page16).

    Hardware/Software Requirements
    • PC-compatible computer running Windows XP
    • Macintosh computer running OS X 10.1 or later
    • Linux computer capable of running Mozilla Firefox 3.0 or later
    Processor speed of 800 MHz (1GHz preferred). A minimum of 128 MB of RAM or more preferred). A modem speed of at least 56k (broadband preferred). Internet browser should be one of the following: Internet Explorer 8.0 or later, Firefox 3.0 or later, Chrome 4.0 or later, or Safari 4.0 or later. Software requirement: Adobe Acrobat Reader 9 or newer.

    Estimated Time to Complete the Educational Activity
    3 hours

    Release Date 
    July 5, 2012

    Expiration Date
    July 3, 2013 

    AUAER Disclosure Policy
    As a provider accredited by the ACCME, the AUAER must ensure balance, independence, objectivity and scientific rigor in all its activities. 
    All persons in a position to control the content of an educational activity (i.e., activity planners and presenters) provided by the AUAER are required to disclose to the provider any relevant financial relationships they have with any commercial interest. The AUAER must determine if an individual's commercial relationships may influence the educational content with regard to exposition or conclusion, and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from serving as planners or presenters, but rather to provide the audience with information on which they can make informed judgments about the material presented. 

    Faculty Disclosures
    Sargent, Eric R.:  Nothing to Disclose
    Winfield, Howard: North Central Section of the AUA, Leadership Position – Financial: No
    Griebling, Tomas: Pfizer: Health Publishing, Scientific Study/Trial; Medtronic: Health Publishing, Scientific Study/Trial. Financial: Yes
    Matlaga, Brian R.: Boston Scientific: Consultant/Advisor, Financial: Yes
    Nehra, Ajay: Nothing to Disclose
    Rosenberg,  Matthew: Astellas: Consultant or Advisor, Meeting Participant/Lecturer Allergan:
    Consultant/Advisor; Forest: Other, Pfizer: Consultant or Advisor/Other 
    Purdue: Consultant or Advisor/Other;  Endo:Consultant or Advisor Financial All: Yes
    Thom, Matthew: Nothing to Disclose

    Planners' Disclosures
    Elspeth McDougall, MD, FRCSC, MHPE
    Associate Dean of Continuing & Simulation Medical Education
    Director, Minimally Invasive Surgery Education Center
    Chair, AUA Office of Education
    University of California – Irvine
    Irvine, CA
    Disclosure: Ethicon Endo-Surgery: Other: Equipment Support, Other: Equipment Support ; Karl Storz Endoscopy America: Other: Equipment Support

    Amling, Christopher Lee: Janssen: Meeting Participant or Lecturer
    Badlani, Gopal: Olympus: Scientific Study or Trial; Allergan: Scientific Study or Trial; Lithotripsy Group: Piedmont Stone & Physcian Discovery: Investment Interest
    Carroll, Peter Robert: NIH: Scientific Study or Trial ; Department of Defense: Scientific Study or Trial ; Myriad Genetics: Scientific Study or Trial; Genomic Health: Scientific Study or Trial; Abbott Pharmaceuticals: Scientific Study or Trial; AUA Update: Leadership Position; Astra Zeneca: Meeting Participant or Lecturer
    Cohen, Marc S.: Nothing to disclose
    Flanigan, Robert C.: NIDDK (NIH): Consultant or Advisor; WJ Weiser: Employee; National Cancer Institute: Scientific Study or Trial
    Fulgham, Pat Fox: Urology Clinics of North Texas: Investment Interest
    Gilbert, Bruce R.: Bayer Healthcare Pharmaceuticals Inc.: Scientific Study or Trial; Auxilium: Scientific Study or Trial; Clarus Pharmaceutcals: Scientific Study or Trial
    Hernandez, Christina: Nothing to disclose
    Jarrard, David F.: Johnson and Johnson: Consultant or Advisor
    Joseph, David B.: Tengion: Scientific Study or Trial; Centers for Disease Control and Prevention: Scientific Study or Trial
    Kogan, Barry A.: Watson Pharmaceuticals: Consultant or Advisor; United Urology: Investment Interest
    Lee, Benjamin R.: Nothing to disclose
    Mathe, Mary: Nothing to disclose
    McDougall, Elspeth Marguerita: Ethicon Endo-Surgery: Other: Equipment support , Other: Equipment Support ; Karl Storz Endoscopy America: Other: Equipment Support
    Mian, Badar Munir: Nothing to disclose
    Mourtzinos, Arthur P.: Johnson & Johnson: Other: Proctor, pelvic floor cadaver lab instructor; Allergan: Other: Lecturer ; Coloplast: Other: Proctor, pelvic floor cadaver lab instructor ; American Medical Systems: Other: Proctor, pelvic floor cadaver lab instructor ; Astellas: Other: Lecturer
    Parsons, J. Kellogg: AMS: Meeting Participant or Lecturer
    Sandhu, Jaspreet Singh: American Medical Systems: Consultant or Advisor
    Steers, William Donald: National Institutes of Health: Consultant or Advisor, Meeting Participant or Lecturer; Food and Drug Administration: Consultant or Advisor; Allergan: Scientific Study or Trial; New England Research Institute (NERI): Consultant or Advisor, Scientific Study or Trial
    Stoffel, John T.: Nothing to disclose
    Sundaram, Chandru P.: Nothing to disclose
    Sweet, Robert Marten: Red Llama Incorporated: Leadership Position,Investment Interest,Owner, Product Development,Employee ; American Medical Systems Holding, Inc.: Meeting Participant or Lecturer,Scientific Study or Trial; Coruthers Health Consulting: Consultant or Advisor; Allergan: Scientific Study or Trial;
    Medtronic: Scientific Study or Trial; Olympus: Other: International Surgical Simulation Fellowship
    Wang, Zhou: Nothing to disclose
    Wein, Alan J.: ENDO Pharmaceuticals: Consultant or Advisor,Meeting Participant or Lecturer; Allergan: Consultant or Advisor,Meeting Participant or Lecturer; Medtronic: Consultant or Advisor,Meeting Participant or Lecturer; Ferring Pharmaceuticals: Consultant or Advisor, Meeting Participant or Lecturer; Pfizer: Consultant or
    Advisor, Meeting Participant or Lecturer; Astellas: Consultant or Advisor, Meeting Participant or Lecturer 
    Resolution of Identified Conflict of Interest
    All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
    • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
    • Limit content to evidence with no recommendations
    • Introduction of a debate format with an unbiased moderator (point-counterpoint)
    • Inclusion of moderated panel discussion
    • Publication of a parallel or rebuttal article for an article that is felt to be biased
    • Limit equipment representatives to providing logistics and operation support only in procedural
    • Divestiture of the relationship by faculty
    Commercial Support Acknowledgement Support for this activity is provided by educational grants from Astellas Scientific and Medical Affairs, Inc., Cook Medical, Endo Pharmaceuticals, HealthTronics and Lilly USA, LLC. 


    Off-label or Unapproved Use of Drugs or Devices
    It is the policy of the AUAER to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
    The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUAER.

    Evidence Based Content 
    As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUAER to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias. 
    Copyright © 2012 American Urological Association Education and Research, Inc.

    Privacy Policy

    Denise Williams, MEd
    Enduring Materials Coordinator
    Office of Education
    American Urological Association
    1000 Corporate Boulevard
    Linthicum, MD 21090
    P 410-689-3751
    F 410-689-3904